Recent Violence Targeted At Doctors In China Could Spell Trouble For Clinical Trials
This article was originally published in PharmAsia News
Executive Summary
Amid tense doctor-patient relations, high-profile adverse events in clinical trials have put strains on an already challenging environment for drug development in China.